The follow-up excision (FUE) results were analyzed from 370 cases diagnosed as
intraductal papilloma on breast core needle biopsy (CNB) with no history of malignancy or …

Background The aim of the study was to determine the upgrade rate on excision of
intraductal papilloma (IDP) without atypia diagnosed on breast core needle biopsy (CNB) …

Background: Classifying papillary lesions of the breast on core biopsy (CB) is challenging.
Although traditionally all such lesions were surgically excised, at present, conservative …

Background The optimal management of intraductal papillomas (IPs) without atypia
diagnosed on needle core biopsy (NCB) is unclear. This study analyzed the malignancy risk …

Background The clinical management of nonmalignant breast papillary lesions diagnosed at
core-needle biopsy (CNB) is controversial. A meta-analysis was performed to evaluate …

Background When a papillary lesion is identified on core biopsy of an impalpable breast
lesion, standard practice involves excisional biopsy. Recent literature has questioned the …

PURPOSE We aimed to estimate the upgrading rate of core-needle biopsy (CNB)-
diagnosed papillary breast lesions to atypical or malignant papillary lesions on subsequent …

Objective To compare malignancy underestimation rates in the case of percutaneous
diagnosis of borderline breast lesions (B3) at 14-g core-needle-biopsy (CNB) and at 11-g …

Intraductal papilloma falls under the category of benign breast mass. However, recent
studies show that it can harbor occult carcinoma. The management of benign intraductal …

BACKGROUND: The purpose of this study was to determine the accuracy of core needle
biopsy (CNB) diagnoses of papillary breast lesions, and to identify the risk factors and …